146 related articles for article (PubMed ID: 19155370)
21. Recent trends in chemotherapy of leprosy.
Parikh DA; Maniar JK; Parikh AC; Ganapati R
J Assoc Physicians India; 1985 Sep; 33(9):593-5. PubMed ID: 3912375
[No Abstract] [Full Text] [Related]
22. [Antibacterial chemotherapy in leprosy: principles, objectives and recommendations].
Sansarricq H
Acta Leprol; 1986; 4(3):355-62. PubMed ID: 3551474
[No Abstract] [Full Text] [Related]
23. Swollen Ears and Nose Bleeding Accompanied by Skin Papules.
Bauer B; Trautmann A
Pediatr Dermatol; 2015; 32(6):863-4. PubMed ID: 26584694
[No Abstract] [Full Text] [Related]
24. Steroid therapy in recent "quiet nerve paralysis" in pure neuritic leprosy.
Jaiswal AK; Shetty MK
Indian J Lepr; 1991; 63(2):223-5. PubMed ID: 1783791
[No Abstract] [Full Text] [Related]
25. Evolution of the modern chemotherapy of leprosy.
Levy L
Lepr Rev; 1983 Jun; Spec No():69-83. PubMed ID: 6350773
[No Abstract] [Full Text] [Related]
26. Dapsone drug resistance in the MDT era.
Roche PW; Neupane KD; Failbus SS; Butlin CR
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
[No Abstract] [Full Text] [Related]
27. [Hansen's disease: case report and review of literature].
Concha R M; Cossio T ML; Salazar S I; Fich S F; Pérez C C; González B S
Rev Chilena Infectol; 2008 Feb; 25(1):64-9. PubMed ID: 18273528
[TBL] [Abstract][Full Text] [Related]
28. Dapsone syndrome: an incomplete form.
Jaswal R; Thami GP; Kanwar AJ
Indian J Lepr; 1998; 70(2):229-30. PubMed ID: 9724867
[No Abstract] [Full Text] [Related]
29. Multi-drug therapy of leprosy.
Ramu G
Indian J Lepr; 1985; 57(3):465-82. PubMed ID: 2420903
[No Abstract] [Full Text] [Related]
30. Facial reversal reaction: a dermatological emergency.
Marzano AV; Tosi D; Cusini M; Nunzi E; Massone C; Crosti C
J Dermatol; 2012 Feb; 39(2):203-5. PubMed ID: 21951390
[No Abstract] [Full Text] [Related]
31. Borderline Lepromatous Leprosy with Type 1 (Reversal) Reactions in a Chinese Man.
Fu X; Liu H; Zhang F
Am J Trop Med Hyg; 2015 Aug; 93(2):207-209. PubMed ID: 26251526
[No Abstract] [Full Text] [Related]
32. Combinations involving dapsone, rifampin, clofazimine, and ethionamide in the treatment of M. leprae infections in mice.
Shepard CC
Int J Lepr Other Mycobact Dis; 1976; 44(1-2):135-9. PubMed ID: 945234
[No Abstract] [Full Text] [Related]
33. Treatment of Hansen's disease.
Alto WA
Am Fam Physician; 2002 Apr; 65(7):1280, 1282; author reply 1282. PubMed ID: 11996412
[No Abstract] [Full Text] [Related]
34. The response to chemotherapy of serum Mycobacterium leprae-specific antigen in multibacillary leprosy patients.
Roche PW; Britton WJ; Neupane KD; Failbus SS; Cho SN; Theuvenet WJ
Am J Trop Med Hyg; 1991 Jun; 44(6):702-8. PubMed ID: 1858971
[TBL] [Abstract][Full Text] [Related]
35. Primary resistance to single and multiple drugs in leprosy--a mouse footpad study.
Shetty VP; Uplekar MW; Antia NH
Lepr Rev; 1996 Dec; 67(4):280-6. PubMed ID: 9033198
[TBL] [Abstract][Full Text] [Related]
36. Isoprodian and rifampicin in the treatment of leprosy: a descriptive evaluation of therapy durations in 475 Paraguayan leprosy patients.
Pritze S; Alvarenga AE; Leguizamon O; Haubitz I
Chemotherapy; 1989; 35(5):373-82. PubMed ID: 2676405
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic prospects for paucibacillary leprosy.
Katoch K
Indian J Lepr; 2000; 72(3):351-61. PubMed ID: 11105276
[No Abstract] [Full Text] [Related]
38. Committee 4: workshop on experimental chemotherapy of leprosy.
Int J Lepr Other Mycobact Dis; 1979 Jun; 47(2 Suppl):297-303. PubMed ID: 378876
[No Abstract] [Full Text] [Related]
39. Mycobacterium leprae and Mycobacterium haemophilum co-infection in an iatrogenically immunosuppressed patient.
SoRelle JA; Beal SG; Scollard DM; Gander RM; Cohen J; Nuara A; Nations S; Cavuoti D
Diagn Microbiol Infect Dis; 2014 Apr; 78(4):494-6. PubMed ID: 24439137
[TBL] [Abstract][Full Text] [Related]
40. Leprosy.
Marcos LA; Conerly S; Walker S
Am J Trop Med Hyg; 2014 Aug; 91(2):216. PubMed ID: 25100789
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
